Skip to content

A study on ayurveda drugs Bibhitakadi Kwatha & Avalgujadi Lepa in the treatment of skin disease

A Clinical Study to Evaluate The Efficacy of Bibhitakadi Kwatha & Avalgujadi Lepa in The Management of Shwitra (Vitiligo) - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/09/073884
Enrollment
60
Registered
2024-09-13
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L80- Vitiligo

Interventions

None listed

Sponsors

Dr.Sarvepalli Radhakrishnan Rajasthan Ayurved Univetrsity ,Jodhpur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with signs and symptoms of Shwitra Roga, specifically skin depigmentation (Twak Vaivarnya), will be selected for this study. This includes individuals exhibiting the classical signs and symptoms of Shwitra, regardless of sex, aged between 18 and 60 years. Participants must be willing to sign the consent form, take the prescribed medicine properly, adhere to dietary and lifestyle guidelines (Pathya - Apathya), and be cooperative in following all study instructions.

Exclusion criteria

Exclusion criteria: Participants will be excluded if they have severe skin disorders, chronic systemic diseases, sexually transmitted diseases, uncontrolled diabetes mellitus, blood-related disorders, or organ failure. Other exclusions include those on medication for the same illness, unwilling participants, patients with leprosy, albinism, pregnant or lactating women, patches from trauma, burns, or chemical exposure, long-term steroid or cytotoxic treatment, adverse reactions to treatment, and malignancy.

Design outcomes

Primary

MeasureTime frame
The primary outcome of the clinical study evaluating the efficacy of Bibhitakadi Kwatha and Avalgujadi Lepa in the management of Shwitra (Vitiligo).Timepoint: Total study time 90 days Follow up at every 2 weeks

Secondary

MeasureTime frame
Bibhitakadi Kwatha & Avalgujadi Lepa will provide a safe & effective treatment. Improve the Quality of life & wellbeing Timepoint: at every 15 days progress & efficacy will be assesed

Countries

India

Contacts

Public ContactDr Ayushi Bhaskar

Madan Mohan Malviya govt ayurved college Radaji circle Ambamata udaipur

drindusharma4@gmail.com7976972210

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026